Market Research Logo

MacroGenics, Inc. - Product Pipeline Review - 2016

MacroGenics, Inc. - Product Pipeline Review - 2016

Summary

Global Markets Direct’s, ‘MacroGenics, Inc. - Product Pipeline Review - 2016’, provides an overview of the MacroGenics, Inc.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by MacroGenics, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

  • The report provides a snapshot of the pipeline therapeutic landscape of MacroGenics, Inc.
  • The report provides overview of MacroGenics, Inc. including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses MacroGenics, Inc.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features MacroGenics, Inc.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects
Reasons to buy
  • Evaluate MacroGenics, Inc.’s strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for MacroGenics, Inc.
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding MacroGenics, Inc.’s pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope


MacroGenics, Inc. Snapshot
MacroGenics, Inc. Overview
Key Information
Key Facts
MacroGenics, Inc. - Research and Development Overview
Key Therapeutic Areas
MacroGenics, Inc. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Partnered Products
Partnered Products/Combination Treatment Modalities
Pipeline Products - Out-Licensed Products
Out-Licensed Products/Combination Treatment Modalities
MacroGenics, Inc. - Pipeline Products Glance
MacroGenics, Inc. - Late Stage Pipeline Products
Phase III Products/Combination Treatment Modalities
MacroGenics, Inc. - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
MacroGenics, Inc. - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
MacroGenics, Inc. - Drug Profiles
margetuximab
Product Description
Mechanism of Action
R&D Progress
teplizumab
Product Description
Mechanism of Action
R&D Progress
enoblituzumab
Product Description
Mechanism of Action
R&D Progress
MGD-006
Product Description
Mechanism of Action
R&D Progress
MGD-007
Product Description
Mechanism of Action
R&D Progress
MGD-009
Product Description
Mechanism of Action
R&D Progress
MGD-010
Product Description
Mechanism of Action
R&D Progress
MGA-012
Product Description
Mechanism of Action
R&D Progress
MGD-013
Product Description
Mechanism of Action
R&D Progress
MGD-014
Product Description
Mechanism of Action
R&D Progress
Monoclonal Antibodies to Target DR5 for Oncology
Product Description
Mechanism of Action
R&D Progress
Monoclonal Antibodies to Target EphA2 and CD3 for Breast Cancer
Product Description
Mechanism of Action
R&D Progress
Monoclonal Antibodies to Target IL13Ralpha2 and CD3 for Melanoma, Glioblastoma Multiforme and Medulloblastoma
Product Description
Mechanism of Action
R&D Progress
Monoclonal Antibodies to Target ROR1 and CD3 for Oncology
Product Description
Mechanism of Action
R&D Progress
Monoclonal Antibody Conjugate to Target B7-H3 for Oncology
Product Description
Mechanism of Action
R&D Progress
MacroGenics, Inc. - Pipeline Analysis
MacroGenics, Inc. - Pipeline Products by Target
MacroGenics, Inc. - Pipeline Products by Route of Administration
MacroGenics, Inc. - Pipeline Products by Molecule Type
MacroGenics, Inc. - Pipeline Products by Mechanism of Action
MacroGenics, Inc. - Recent Pipeline Updates
MacroGenics, Inc. - Dormant Projects
MacroGenics, Inc. - Company Statement
MacroGenics, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
MacroGenics, Inc., Key Information
MacroGenics, Inc., Key Facts
MacroGenics, Inc. - Pipeline by Indication, 2016
MacroGenics, Inc. - Pipeline by Stage of Development, 2016
MacroGenics, Inc. - Monotherapy Products in Pipeline, 2016
MacroGenics, Inc. - Partnered Products in Pipeline, 2016
MacroGenics, Inc. - Partnered Products/ Combination Treatment Modalities, 2016
MacroGenics, Inc. - Out-Licensed Products in Pipeline, 2016
MacroGenics, Inc. - Out-Licensed Products/ Combination Treatment Modalities, 2016
MacroGenics, Inc. - Phase III, 2016
MacroGenics, Inc. - Phase II, 2016
MacroGenics, Inc. - Phase I, 2016
MacroGenics, Inc. - Preclinical, 2016
MacroGenics, Inc. - Pipeline by Target, 2016
MacroGenics, Inc. - Pipeline by Route of Administration, 2016
MacroGenics, Inc. - Pipeline by Molecule Type, 2016
MacroGenics, Inc. - Pipeline Products by Mechanism of Action, 2016
MacroGenics, Inc. - Recent Pipeline Updates, 2016
MacroGenics, Inc. - Dormant Developmental Projects,2016
MacroGenics, Inc., Other Locations
MacroGenics, Inc., Subsidiaries
List of Figures
MacroGenics, Inc. - Pipeline by Top 10 Indication, 2016
MacroGenics, Inc. - Pipeline by Stage of Development, 2016
MacroGenics, Inc. - Monotherapy Products in Pipeline, 2016
MacroGenics, Inc. - Partnered Products in Pipeline, 2016
MacroGenics, Inc. - Out-Licensed Products in Pipeline, 2016
MacroGenics, Inc. - Pipeline by Top 10 Target, 2016
MacroGenics, Inc. - Pipeline by Route of Administration, 2016
MacroGenics, Inc. - Pipeline by Molecule Type, 2016
MacroGenics, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report